{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Deharo P"],"funding":["French Government and managed by the National Research Agency"],"pagination":["6117"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9604905"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["11(20)"],"pubmed_abstract":["<h4>Background</h4>Transcatheter aortic valve implantation (TAVI) is the preferred treatment for symptomatic severe aortic stenosis (AS) in a majority of patients across all surgical risks.<h4>Patients and methods</h4>Paravalvular leak (PVL) and patient-prosthesis mismatch (PPM) are two frequent complications of TAVI. Therefore, based on the large France-TAVI registry, we planned to report the incidence of both complications following TAVI, evaluate their respective risk factors, and study their respective impacts on long-term clinical outcomes, including mortality.<h4>Results</h4>We identified 47,494 patients in the database who underwent a TAVI in France between 1 January 2010 and 31 December 2019. Within this population, 17,742 patients had information regarding PPM status (5138 with mo"],"journal":["Journal of clinical medicine"],"pubmed_title":["Long-Term Prognosis Value of Paravalvular Leak and Patient-Prosthesis Mismatch following Transcatheter Aortic Valve Implantation: Insight from the France-TAVI Registry."],"pmcid":["PMC9604905"],"funding_grant_id":["ANR-16-RHUS-0003"],"pubmed_authors":["Jaussaud N","du Chayla F","Dumonteil N","Commeau P","Morera P","Iung B","Ferrara J","Porto A","Cuisset T","Glatt N","Gouysse M","Modine T","Vaillier A","Eltchaninoff H","Gariboldi V","Verhoye JP","Deharo P","Leroux L","Gilard M","Benamer H","Beurtheret S","Cayla G","Lefevre T","Collet JP","Collart F","Le Breton H","Theron A","France-TAVI and STOP-AS Investigators"],"additional_accession":[]},"is_claimable":false,"name":"Long-Term Prognosis Value of Paravalvular Leak and Patient-Prosthesis Mismatch following Transcatheter Aortic Valve Implantation: Insight from the France-TAVI Registry.","description":"<h4>Background</h4>Transcatheter aortic valve implantation (TAVI) is the preferred treatment for symptomatic severe aortic stenosis (AS) in a majority of patients across all surgical risks.<h4>Patients and methods</h4>Paravalvular leak (PVL) and patient-prosthesis mismatch (PPM) are two frequent complications of TAVI. Therefore, based on the large France-TAVI registry, we planned to report the incidence of both complications following TAVI, evaluate their respective risk factors, and study their respective impacts on long-term clinical outcomes, including mortality.<h4>Results</h4>We identified 47,494 patients in the database who underwent a TAVI in France between 1 January 2010 and 31 December 2019. Within this population, 17,742 patients had information regarding PPM status (5138 with mo","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Oct","modification":"2025-04-19T12:06:48.279Z","creation":"2025-04-19T12:06:48.279Z"},"accession":"S-EPMC9604905","cross_references":{"pubmed":["36294438"],"doi":["10.3390/jcm11206117"]}}